Indianapolis
16 Tech Community Corporation broke ground in December of 2018 on the $30 million Advanced Research and Innovation Facility in Indianapolis. The Indiana Biosciences Research Institute will lease over 67,000 sf on the first three floors of the building to accommodate researchers engaged in the study of diabetes, nutrition, and metabolics. Indiana University School of Medicine will locate the Center for Regenerative Medicine's molecular therapeutics program in 12,000 sf of the facility, which will also house the Central Indiana Corporate Partnership. Completion is expected in mid-2020. The five-story building is being developed by Browning Investments and represents the first phase of construction of the 16 Tech Innovation District.